Valerie Landry

Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Enhancing antibiotic activity against Escherichia coli and Klebsiella pneumoniae with optimised pyridylpiperazine AcrAB-TolC efflux pump inhibitors.

Enhancing antibiotic activity against Escherichia coli and Klebsiella pneumoniae with optimised pyridylpiperazine AcrAB-TolC efflux pump inhibitors.

Journal: European journal of medicinal chemistry

Published: May 01, 2026

A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2.

A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2.

Journal: European journal of medicinal chemistry

Published: October 01, 2025

Discovery of pyrimidine-based small activators of insulin degrading enzyme.

Discovery of pyrimidine-based small activators of insulin degrading enzyme.

Journal: European journal of medicinal chemistry

Published: June 10, 2025

Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin-degrading enzyme, a new molecular vulnerability in multiple myeloma.

Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin-degrading enzyme, a new molecular vulnerability in multiple myeloma.

Journal: British journal of pharmacology

Published: October 14, 2024

N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease.

N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease.

Journal: European journal of medicinal chemistry

Published: June 13, 2024

Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis.

Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis.

Journal: International journal of molecular sciences

Published: November 03, 2023

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.

Journal: European journal of medicinal chemistry

Published: December 05, 2022

Identification of indole-based activators of insulin degrading enzyme.

Identification of indole-based activators of insulin degrading enzyme.

Journal: European journal of medicinal chemistry

Published: August 12, 2021

NMR Spectroscopy of the Main Protease of SARS-CoV-2 and Fragment-Based Screening Identify Three Protein Hotspots and an Antiviral Fragment.

NMR Spectroscopy of the Main Protease of SARS-CoV-2 and Fragment-Based Screening Identify Three Protein Hotspots and an Antiviral Fragment.

Journal: Angewandte Chemie (International ed. in English)

Published: August 03, 2021

Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.

Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.

Journal: European journal of medicinal chemistry

Published: March 18, 2019

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.

Journal: Bioorganic chemistry

Published: July 16, 2018

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.

Journal: Scientific reports

Published: June 05, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026